# Dilon Technologies

received FDA approval and launched MarginProbe 2, a next-generation radiofrequency-spectroscopy probe for intraoperative breast-tumor margin assessment in breast-conserving surgery, continuing the MarginProbe technology line through a pivotal trial for the upgraded device.

Source: https://en.bioecon.ru/companies/dilon-technologies/
Updated: 2026-07-20

- Country: United States

## Technologies

- [Intraoperative molecular diagnostics](https://en.bioecon.ru/technology/intraoperative-molecular-diagnostics/)